DAVID R. LIU, Ph.D.
Founder of Ensemble Therapeutics
Professor of Chemistry and Chemical Biology at Harvard University
Howard Hughes Medical Institute Investigator
Scientific Advisory Board
DAVID ARMISTEAD, Ph.D.
Entrepreneur-in-Residence at Third Rock Ventures
Co-founder of Kinetix Pharmaceuticals
Former VP and Site Head of the Amgen Cambridge Research Center
FRANCIS BARANY, Ph.D.
Professor, Department of Microbiology, Weill Cornell Medical College
Member of the joint Cornell/Sloan-Kettering Institute’s Molecular Biology Program
SIR SIMON CAMPBELL, CBE, FRS, FMedSci
Former SVP for Pfizer Worldwide Discovery and Medicinals R&D in Europe
Former President of the Royal Society of Chemistry
PAT CONFALONE, Ph.D.
Consultant to the biotechnology and pharmaceutical industry at Confalone Consulting
Previously VP Research & Development, DuPont Crop Protection and SVP Bristol-Myers Squibb
GERARD EVAN, Ph.D., FRS
Sir William Dunn Professor of Biochemistry and Head of Department of Biochemistry at the University of Cambridge
Previously Professor of Cancer Research at UCSF Helen Diller Family Comprehensive Cancer Center
MARK MURCKO, Ph.D.
SVP of Strategy at Schrödinger
Former VP, Chief Technology Officer and Chair of the Scientific Advisory Board of Vertex Pharmaceuticals
CRAIG A. SMITH, Ph.D.
Co-founder, VLST Scientific Fellow and Chairman of the Scientific Advisory Board of VLST Corporation
MICHAEL E. WEINBLATT, M.D.
Co-director of Clinical Rheumatology at the Brigham and Women’s Hospital
John R. Riedman Professor of Medicine at Harvard Medical School